ImaCor Inc

ImaCor Inc. is a privately held company based in Jericho, New York, with 18 employees. The company generates approximately $11 million in annual revenue. ImaCor designs, manufactures, and distributes hTEE technology, a critical care solution for optimizing cardiac performance. Their hTEE technology, comprised of the EVO ultrasound systems and the ClariTEE® probe, allows for continuous, direct cardiac visualization over extended periods. The disposable ClariTEE® probe can remain indwelling for up to 72 hours, enabling clinicians to monitor cardiac filling and function episodically. ImaCor's technologies are used by clinicians to guide and assess the effectiveness of cardiac therapies, allowing for timely adjustments in patient management. ImaCor's hTEE technology is designed to deliver a superior clinical outcome and cost-effective resource utilization for patients, clinicians, and hospital administrators. The company's vision is to establish ultrasound-guided hemodynamic management as the global standard for advanced critical care, significantly impacting the quality and economics of patient care. For more information on ImaCor Inc. and their hTEE technology, please visit www.imacorinc.com.